Enkephalin may mediate euphoria and drive-reduction reward.
about
Alcoholism: A Systems Approach From Molecular Physiology to Addictive BehaviorPharmacological evidence for a motivational role of kappa-opioid systems in ethanol dependenceThe Influence of Palatable Diets in Reward System Activation: A Mini ReviewRowers' high: behavioural synchrony is correlated with elevated pain thresholdsDistinct Roles of Opioid and Dopamine Systems in Lateral Hypothalamic Intracranial Self-Stimulation.Intracranial self-stimulation to evaluate abuse potential of drugs.From opiate pharmacology to opioid peptide physiology.Psychotherapeutic benefits of opioid agonist therapy.Light and electron-microscopic study of leucine enkephalin immunoreactivity in the cat claustrum.Endorphins: the basis of pleasure?Differential involvement of endogenous opioids in sucrose consumption and food reinforcement.Drug motivation and abuse: a neurobiological perspective.Endorphins: endogenous substrates for dental analgesia?Recent advances in the understanding of acupuncture.Opioid system functional regulation in neurological disease management.Nalmefene for treatment of alcohol dependence.The role of beta-endorphin in the acute motor stimulatory and rewarding actions of cocaine in mice.Use of psychotropic drugs in treatment of methadone maintained narcotic addicts.Improvement of cocaine-induced neuromodulator deficits by the neuronutrient Tropamine.Neurobiology of behavior: anatomic and physiological implications related to epilepsy.Stimulant effects of enkephalin microinjection into the dopaminergic A10 area.Changes in simple and complex behaviors following kindled seizures in rats: opioid and nonopioid medication.Opioid peptides and perinatal development: is beta-endorphin a natural teratogen? Clinical implications.Anatomical distribution of mu, delta, and kappa opioid- and nociceptin/orphanin FQ-stimulated [35S]guanylyl-5'-O-(gamma-thio)-triphosphate binding in guinea pig brain.Fluoxetine alters mu opioid receptor expression in obese Zucker rat extrahypothalamic regions.The adenosine A2A receptor agonist CGS 21680 decreases ethanol self-administration in both non-dependent and dependent animals.Biochemical and Clinical Impact of Organic Uremic Retention Solutes: A Comprehensive Update.Behavioral steering in dual and social states of conation by the amygdala, hypothalamus, ventral striatum, and thalamus.Biobehavioral bases of the reinforcing properties of opiate drugs.Brain endorphins: possible role in long-term memory.The use of the plasma concentration-effect relationship as a tool for the study of the mechanism of action of naloxone effects on mood and endocrine function.Opiate receptor avidity in the thalamus is sexually dimorphic in the elderly.Naloxone and naltrexone in mental illness and tardive dyskinesia.
P2860
Q22241964-A2B835A7-FAA4-4ED7-86C3-70A6AC471FA6Q24658266-AA34A362-7C8E-43ED-A432-0EF2F60B1C25Q26752942-5566B5FB-32B2-42A4-9177-15DB88C8644CQ28258642-F850AC2D-8E87-47E9-8FE6-99A9D75965DAQ33636492-4F0144E2-E130-43F2-9BFD-0A529473C7F8Q33845750-0785A6E6-3410-4028-9FBD-12433D9E2D04Q33967412-7AD92161-990D-4B0E-ADA5-27351CECB6AEQ34014407-6D7E8549-75E2-4315-8B96-C492802713EAQ34413431-38106064-0FF4-44AA-8C93-D59EB06B7F7AQ35228108-4E3F1E15-72DC-43D8-B0C1-5C2C41B00469Q35792592-94CA8037-3376-45A2-9179-0809C508B3FEQ36330276-3DB3CEBD-BC26-4FFC-AC0A-D116DD1D61F5Q36836871-19D3C0AD-C892-4E6B-9571-CAE7E699DAECQ36998824-7A98C039-C27E-461F-953B-7330E0B3BC53Q37782045-CDE096A9-370E-49E1-ABC5-1A7A9CA166E6Q37792101-02835F27-24EC-406D-BF4E-A857E697A014Q38783722-7334BF9D-0F1C-4C79-A4EB-53399E8EDE6DQ39236556-0579AA54-C135-4330-B84C-2ADC0BBAF97AQ39472665-E3DDBE72-BED1-4AA0-A0CE-030E4FB70EB4Q41470067-3DF2144F-A2FD-4180-9371-50D489EC6455Q41515280-D113296A-1034-4D6C-B9FD-0767052A1073Q44330964-7A60941F-71AE-4BFB-8F79-E903D636AE74Q44337504-60C26AEF-E743-4997-852D-22659E7C27BCQ44347382-E700904C-27ED-4C59-94EF-87598F588FB3Q44351893-F6B632ED-1B4A-4B1B-93EA-7F15BD573E72Q45864839-11432735-D308-4E5E-847E-5F7D6443DA18Q47216784-5393F03A-91B6-468A-8C43-81911B120CEFQ49012262-B05DC60E-FDA6-48B5-ACB0-6B2DEB503D48Q49079488-9605DEDD-310F-4396-B395-E10F0E749CFDQ49079529-B363804D-A361-4760-94C0-0759286B785CQ51107194-001C319C-5FA1-42C6-8A4C-EA99E5155B50Q51973335-BEB073D5-42BD-4A9C-84EC-4D4A1931C1F6Q52100145-C19FB199-01D1-45E6-B05E-8EE02A4B3032
P2860
Enkephalin may mediate euphoria and drive-reduction reward.
description
1977 nî lūn-bûn
@nan
1977年の論文
@ja
1977年学术文章
@wuu
1977年学术文章
@zh-cn
1977年学术文章
@zh-hans
1977年学术文章
@zh-my
1977年学术文章
@zh-sg
1977年學術文章
@yue
1977年學術文章
@zh
1977年學術文章
@zh-hant
name
Enkephalin may mediate euphoria and drive-reduction reward.
@en
type
label
Enkephalin may mediate euphoria and drive-reduction reward.
@en
prefLabel
Enkephalin may mediate euphoria and drive-reduction reward.
@en
P2860
P356
P1433
P1476
Enkephalin may mediate euphoria and drive-reduction reward.
@en
P2093
P2860
P2888
P304
P356
10.1038/266556A0
P407
P577
1977-04-01T00:00:00Z
P6179
1045850842